Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
An Alabama couple has filed a Pradaxa bleeding lawsuit against Boehringer Ingelheim Pharmaceuticals Inc., alleging the wife suffered severe uncontrollable bleeding requiring immediate medical attention after taking the company’s popular anticoagulant.
Plaintiffs Mary and James B. have jointly filed the Pradaxa lawsuit, claiming that Boehringer Ingelheim made misleading claims regarding the effectiveness, safety, and benefits of Pradaxa.
Because of those claims, Mary, her husband, and her doctors were allegedly unaware of the Pradaxa bleeding risk and other Pradaxa complications.
What is Pradaxa?
Pradaxa is an anticoagulant (or blood thinning treatment) that is part of a group of drugs known as direct thrombi inhibitors. This class of drugs is regularly prescribed to treat or prevent strokes and blood clots in patients suffering from atrial fibrillation.
The FDA approved Pradaxa for use in the United States back in October 2010, making it the first new anticoagulant to receive FDA approval in over 50 years. Prior to that, most patients and doctors relied on the tried and true blood thinner Warfarin.
Although Boehringer Ingelheim marketed Pradaxa as superior to Warfarin because Pradaxa does not require a strict diet or blood monitoring, patients began reporting bleeding complications soon after the new drug hit the market.
While bleeding and internal bleeding risks are a potential complication of all blood thinners, the difference between Warfarin and Pradaxa is that the former has a reversal agent (Vitamin K), which can be administered to stop the Pradaxa complications.
At present, there is no comparable Pradaxa antidote to immediately combat life threatening bleeding risks many patients have allegedly endured.
Pradaxa Lawsuit Allegations
Mary alleges that she was first prescribed the Pradaxa anticoagulant in November 2011, in order to treat her non-valvular atrial fibrillation. She continued to take the prescription blood thinner until around September 2014, at which time she was hospitalized for six days in order to treat severe gastrointestinal bleeding allegedly caused by Pradaxa side effects.
Because she suffered Pradaxa internal bleeding complications, Mary needed three red blood cell transfusions and was forced to undergo an esophagogastroduodenoscopy (a diagnostic procedure) and a colonoscopy.
Mary’s Pradaxa lawsuit alleges that as a result of using Pradaxa, she suffered from bodily injuries, economic losses, pain and suffering, loss of enjoyment of life, medical expenses, and loss of consortium.
Mary and her husband are suing Boehringer Ingelheim to recover some of the costs associated with her injury and treatment.
The Pradaxa Lawsuit is Case No. 3:15-px-00993-DRH-SCW and is part of the Pradaxa MDL In re: Pradaxa (Dabigatran Extextilate) Products Liability Litigation, MDL No. 2385, in the U.S. District
In general, Pradaxa lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Pradaxa attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Pradaxa class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Pradaxa Class Action Lawsuit Investigation
If you, or a loved one, experienced Pradaxa side effects, you may have a legal claim. Submit your information now for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.